The therapy, called Sotrovimab from GlaxoSmithKline and Vir Biotechnology, is now no longer authorized by the Food and Drug Administration in Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey and New York, as well as Puerto Rico and the Virgin Islands, while BA.2 is the prevailing COVID-19 strain, the agency announced Friday.
In those impacted areas, BA.2 is estimated to account for more than 50% of new cases as of March 19, according to data from the Centers for Disease Control and Prevention. BA.2 has been especially dominant across the Northeast -- a prevalence reflected by the regions where the government is now pulling back Sotrovimab's licensure. The CDC estimates BA.2 accounts for more than a third of new cases nationally.Monoclonals have become a mainstay for COVID treatment.
In January, the FDA paused its authorization for two previous monoclonal therapies from Regeneron and Eli Lilly, after
Bla bla bla Covid bla bla Pfizer 💰💰💰
Paused? It has never been available to us where I live. Rural areas didn't get any for anybody to use. Biden turned his back on us farmers and rednecks.
Because it doesn't do what it promised and it's stupidly expensive
Get your freaking vaccine!
Lol, it’s as if conservatives pushed an fake cure to pad their bottom line. Funny how that keeps happening
OMG!!! Fastest way to make money 2022, Use this promo code: SLIMZY To get up to 300% bonus of your first deposit on “Click the link below”👇👇
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ABC7 - 🏆 67. / 68 Read more »
Source: fox32news - 🏆 547. / 51 Read more »